1 Wardlaw JM，Murray V，Berge E，et al. Recombinant

tissue plasminogen activator for acute ischaemic

stroke：an updated systematic review and meta

analysis[J]. Lancet，2012，379：2364-2372.

2 Khoury R，Jung R，Nanda A，et al. Overview of key

factors in improving access to acute stroke care[J].

Neurology，2012，79：S26-S34.

3 Xu AD，Wang YJ，Wang DZ，et al. Consensus

statement on the use of intravenous recombinant

tissue plasminogen activator to treat acute ischemic

stroke by the Chinese Stroke Therapy Expert Panel[J].

CNS Neurosci Ther，2013，19：543-548.

4 Jauch EC，Saver JL，Adams HP，et al. Guidelines for

the early management of patients with acute ischemic

stroke：A guideline for healthcare professionals

from American Heart Association/American Stroke

Association[J]. Stroke，2013，44：870-947.

5 中华医学会神经病学分会脑血管病学组急性缺血性

脑卒中诊治指南撰写组. 中国急性缺血性脑卒中诊治

指南2010[J]. 中华神经科杂志，2010，43：146-152.

6 Hacke W，Kaste M，Bluhmki E，et al. Thrombolysis

with alteplase 3 to 4. 5 hours after acute ischemic

stroke[J]. N Engl J Med，2008，359：1317-1329.

7 Liao XL，Wang YL，Wang CJ，et al. Thrombolysis

with intravenous recombinant tissue plasminogen

activator 3 to 4. 5 h after acute ischemic stroke in

China[J]. Stroke，2012，43：A62.

8 Kaste M. Thrombolysis，What more does it take?[J].

Stroke，2005，36：200-202.

9 California Acute Stroke Pilot Registry(CAS PR)

Investigators. Prioritizing interventions to improve

rates of thrombolysis for ischemic stroke[J]. Neurology，

2005，64：654-659.

10 Eissa A，Krass I，Levi C，et al. Understanding the

reasons behind the low utilisation of thrombolysis in

stroke[J]. Australas Med J，2013，6：152-167.

11 Grot t a JC，Burgin WS，El-Mitwal li A，et a l.

Intravenous tissue-type plasminogen activator therapy

for ischemic stroke：Houston experience 1996 to

2000[J]. Arch Neurol，2001，58：2009-2013.

12 Katzan IL，Hammer MD，Furlan AJ，et al. Quality

improvement and tissue-type plasminogen activator

for acute ischemic stroke：a Cleveland update[J].

Stroke，2003，34：799-800.

13 Kleindorfer D，Kissela B，Schneider A，et al.

Eligibility for recombinant tissue plasminogen

activator in acute ischemic stroke：a population-based

study[J]. Stroke，2004，35：e27-e29.

14 Schenkel J，Weimar C，Knoll T，et al. R1-systemic

thrombolysis in German stroke units--the experience

from the German stroke data bank[J]. J Neurol，2003，

250：320-324.

15 Wang Y，Liao X，Zhao X，et al. Using recombinant

tissue plasminogen activator to treat acute ischemic

stroke in China：analysis of the results from the

Chinese National Stroke Registry (CNSR)[J]. Stroke，

2011，42：1658-1664.

16 中国脑卒中医疗质量评估（QUEST）协作组. 中国急

性缺血性脑卒中治疗现状[J]. 中华神经科杂志，2009，

42：223-228.

17 石涛. 急性缺血性脑卒中院前延误的研究现状和若干

问题[J]. 中华脑血管病杂志，2012，6：181-184.

18 Mo r r i s DL，Ｒosamond W，Madden K，e t a l .

Prehospital and emergency department delays after

acute stroke：the Genentech Stroke Presentation

Survey[J]. Stroke，2000，31：2585-2590.

19 Kim YS，Park SS，Bae HJ，et al. Stroke awareness

decreases prehospital delay after acute ischemic

stroke in Korea[J]. BMC Neurol，2011，11：2，doi：10.

1186/1471-2377-11-2.

20 Jin H，Zhu S，Wei JW，et al. Factors associated with

prehospital delays in the presentation of acute stroke

in urban China[J]. Stroke，2012，43：362-370.

21 王亚冰，焦力群，王亚东，等. 北京市三甲医院急性脑

血管病患者发病至治疗延误的时间分布[J]. 中国神经

精神疾病杂志，2009，35：22-25.

22 Ｒossnagel K，Jungehulsing GJ，Nolte CH，et al. Outof

hospital delays in patients with acute stroke[J]. Ann

Emerg Med，2004，44：476-483.

23 Yanagida T，Fujimoto S，Inoue T，et al. Causes of

prehospital delay in stroke patients in an urban aging

society[J]. J Clin Gerontol Geriatr，2014，5：77-81.

24 毕齐，张茁，张微微，等. 2270例卒中患者延误诊治时

间的因素分析[J]. 中国脑血管病杂志，2005，2：62-67.

25 杜建蓉，荣秀华. 影响脑卒中患者就诊延迟原因分析

及干预对策[J]. 西部医学，2006，18：164-165.

26 Zerwic J，Hwang SY，Tucco L. Interpretation of

symptoms and delay in seeking treatment by patients

who have had a stroke：exploratory study[J]. Heart

Lung，2007，36：25-34.

27 Faiz KW，Sundseth A，Thommessen B. et al. Factors

related to decision delay in acute stroke[J]. J Stroke

Cerebrovasc Dis，2014，23：534-539.

28 丁国娟，金春华. 急性缺血性脑卒中患者发病至急诊

科时间间隔的影响因素研究[J]. 中国全科医学，2016，

13：1548-1551.

29 Chang KC，Tseng MC，Tan TY. Prehospital delay

after acute stroke in Kaohsiung，Taiwan[J]. Stroke，

2004，35：700-704.

30 Lansberg MG，Schrooten M，Bluhmki E，et al.

Treatment time-specific number needed to treat

estimates for tissue plasminogen activator therapy

in acute stroke based on shifts over the entire range

of the modified Rankin Scale[J]. Stroke，2009，40：

2079-2084.

31 Meretoja A，Strbian D，Mustanoja S，et al. Reducing

in-hospital delay to 20 minutes in stroke thrombosis[J].

Neurology，2012，79：306-313.

32 Meretoja A，Weir L，Ugalde M，et al. Helsinki

model cut stroke thrombosis delays to 25 minutes in

Melbourne in only 4 months[J]. Neurology，2013，81：

1071-1076.

33 Fo r d A L，Wi l l i ams JA，Sp e nc e r M，e t a l .

Reducing door-to-needle times using Toyotas lean

manufacturing painciples and value stream analysis[J].

Stroke，2012，43：3395-3398.

34 王伊龙，吴敌，周勇，等. 中国七城市卒中患者急诊溶

栓情况分析[J]. 中国卒中杂志，2009，4：23-28.

35 Fonarow GC，Smith EE，Saver JL，et al. Timeliness

of tissue-type plasminogen activator therapy in acute

ischemic stroke：patient characteristics，hospital

factors，and outcomes associated with door-to-needle

times within 60 minutes[J]. Circulation，2011，123：

750-758.

36 Fona row GC，Re eve s MJ，Smi t h EE，e t a l .

Characteristics，performance measures，and inhospital

outcomes of the first one million stroke and

transient ischemic attack admissions in get with the

guidelines-stroke[J]. Circ cardiovasc Qual outcomes，

2010，3：291-302.

37 Kapral MK，Silver FL，Richards JA，et al. Registry

of the Canadian stroke net work progress report 2001-

2005[EB/OL]. http：//www.ices.on.ca/Publications/

At la se s -and-Repor t s /2005/RCSN-prog res s -

report-2001-2005(2005-09).

38 黄小钦，贾建平，刘丽旭，等. 早期就诊的急性缺血

性卒中病人未溶栓原因分析[J]. 脑与神经疾病杂志，

2007，15：346-348.

39 Quain DA，Parsons MW，Loudfoot AR，et al.

Improving access to acute st roke therapies：a

cont rolled t r ial of organised pre-hospital and

emergency care[J]. Med J Aust，2008，189：429-433.

40 Coote S，Frost T，Singhal S，et al. Direct to CT：

overcoming barriers to reduce door to needle time in

acute stroke patients[J]. Stroke，2010，11：1505-1510.

41 Beh rens S. Improvement i n s t roke qual i t y

management by an educational programme[J].

Cerebrovasc Dis，2002，13：262-266.

42 Kim SK. Pre-hospital notification reduced the doorto-

needle time for iv t-PA in acute ischaemic stroke[J].

Eur J Neurol，2009，16：1331-1335.

43 李伟，王欢. 完善卒中绿色通道对提高急性缺血性卒

中静脉溶栓率的影响[J]. 重庆医学，2014，16：1979-

1982.

44 邢鹏飞，张永巍，陈蕾，等. 医院诊治模式的改变对急

性缺血性卒中患者救治时间的影响[J]. 中国脑血管病

杂志，2015，12：617-619.